PsychoGenics secures license for ENT1 inhibitor RO7117997 from Roche

PGI Drug Discovery LLC (PsychoGenics), recognized for its phenotypic drug discovery platform, has announced an exclusive license agreement with Roche. This agreement grants PsychoGenics global ... Read More